Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

fda2outsideweb

FDA approves first continuous glucose monitoring system

June 22, 2018 Medical Communications, Sales and Marketing FDA, diabetes, pharma

The US Food and Drug Administration (FDA) has approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people …
News
astrazeneca_sign_sky

AstraZeneca’s Imfinzi becomes India’s first available immunotherapy for lung cancer

June 22, 2018 Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, India, NSCLC, lung cancer, pharma

In a big step forward for India as AstraZeneca announces that its checkpoint inhibitor Imfinzi (durvalumab) has secured approval in …
News
roche__tree

Roche’s Ocrevus cleared for NHS use in relapsing-remitting MS

June 22, 2018 Medical Communications, Sales and Marketing MS, NICE, UK, multiple sclerosis, pharma

Roche and multiple sclerosis (MS) patients across England and Wales are celebrating the news that healthcare watchdog NICE has recommended …
News
920x920

Purdue culls 350 positions, eradicates sales force

June 21, 2018 Medical Communications, Sales and Marketing Purdue Pharma, opioid crisis, opioids, pharma

Bowing to the pressure applied by external groups for the part it has played in the ongoing opioid crisis, Purdue …
News
shutterstock_138095450

Aquinnah Pharmaceuticals receives $3.4 million grant to advance ALS therapies

June 21, 2018 Research and Development, Sales and Marketing Aquinnah Pharmaceuticals, als, amyotrophic lateral sclerosis, pharma

Aquinnah Pharmaceuticals has announced that it has been awarded a $3.4 million grant from the National Institute of Neurological Disorders …
News
Pharma on Facebook

Facebook unveils new feature to battle opioid crisis

June 20, 2018 Medical Communications, Research and Development, Sales and Marketing FDA, Facebook, US, opioid crisis, opioids, pharma

Despite its highly-publicised transgressions recently, tech giant Facebook is looking to do the right thing by wading into the ongoing …
News
valeant_web

FDA rejects Valeant plaque psoriasis lotion over pharmacokinetic concerns

June 19, 2018 Manufacturing and Production, Sales and Marketing FDA, Valeant, pharma, psoriasis

Beleaguered pharma firm Valeant has come up against another bump in the road as its plaque psoriasis lotion Duobrii (halobetasol …
News
roche__tree

Roche buys out rest of Foundation Medicine for $2.4bn

June 19, 2018 Manufacturing and Production, Sales and Marketing Foundation Medicine, Roche, biotech, drugs, pharma, pharmaceutical

Roche has clearly seen significant potential in Foundation Medicine’s work in genomics to pay $2.4 billion to take complete ownership …
News
facilities_lg06

Dr Reddy’s just-approved opioid dependence generic blocked over US patent dispute

June 18, 2018 Sales and Marketing Dr Reddy's, FDA, Mylan, US, opioid crisis, opioid dependence, opioids, suboxone

Dr Reddy’s Laboratories has taken two steps forward an one step back after its generic version of Suboxone Film (buprenorphine/naloxone) …
News
data

Maintaining control: The rising challenges of clinical data management

June 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

From breach scandals to GDPR, data is becoming a more prominent part of our everyday lives. This holds great potential …
Feature
vaccination-2722937_960_720_1

HPV vaccine slashes rate of infection by 86% in UK

June 18, 2018 Medical Communications, Sales and Marketing HPV, biotech, drugs, pharma, pharmaceutical, vaccination

Since the introduction of the vaccination against the Human Papilloma Virus in 2008, there has been an 86% drop in …
News
teva_copy

Teva axes Phase 3 trial into chronic cluster headache

June 18, 2018 Research and Development, Sales and Marketing Teva, fremanezumab, headache, pharma

With the advent of another week, there’s another trial discontinuation in the industry as Teva announces its decision to terminate …
News
opdivo_1_1

BMS’ Opdivo becomes first immuno-oncology agent available in China

June 18, 2018 Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, China, NSCLC, lung cancer, oncology, opdivo, pharma

Bristol-Myers Squibb’s flagship immunotherapy Opdivo (nivolumab) has broken ground to become the first and only PD-1 inhibitor to be made …
News
theresa_may_-_arno_mikkor

£20bn promised to NHS but questions over where money will come from

June 18, 2018 Medical Communications, Sales and Marketing NHS, UK government, biotech, drugs, pharma, pharmaceutical

Theresa May finally attempted to tackle the elephant in the room for the UK government, well, the one other than …
News
top_ten

Top Ten most popular articles on Pharmafile.com this week

June 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Another busy in week in pharma has seen a number of companies release promising data on their drugs, Roche’s study …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026